McRae Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.2M | Sell |
28,388
-370
| -1% | -$178K | 2.8% | 15 |
|
|
2026
Q1 | $14.1M | Sell |
28,758
-445
| -2% | -$242K | 2.93% | 14 |
|
|
2025
Q4 | $16.9M | Sell |
29,203
-1,565
| -5% | -$885K | 3.45% | 10 |
|
|
2025
Q3 | $14.9M | Sell |
30,768
-25
| -0.1% | -$11.6K | 2.96% | 14 |
|
|
2025
Q2 | $12.5M | Buy |
30,793
+3,289
| +12% | +$1.38M | 2.56% | 20 |
|
|
2025
Q1 | $13.7M | Sell |
27,504
-265
| -1% | -$144K | 2.89% | 15 |
|
|
2024
Q4 | $14.4M | Buy |
27,769
+2,080
| +8% | +$1.14M | 2.83% | 16 |
|
|
2024
Q3 | $15.9M | Sell |
25,689
-130
| -0.5% | -$77K | 3.1% | 13 |
|
|
2024
Q2 | $14.3M | Buy |
25,819
+124
| +0.5% | +$71K | 3.26% | 14 |
|
|
2024
Q1 | $14.9M | Buy |
25,695
+1,006
| +4% | +$565K | 3.27% | 12 |
|
|
2023
Q4 | $13.1M | Buy |
24,689
+4,020
| +19% | +$1.95M | 3.28% | 14 |
|
|
2023
Q3 | $10.5M | Buy |
20,669
+8,675
| +72% | +$4.62M | 3.1% | 16 |
|
|
2023
Q2 | $6.26M | Buy |
11,994
+210
| +2% | +$113K | 1.78% | 22 |
|
|
2023
Q1 | $6.79M | Buy |
11,784
+440
| +4% | +$248K | 1.96% | 22 |
|
|
2022
Q4 | $6.25M | Sell |
11,344
-515
| -4% | -$273K | 1.83% | 24 |
|
|
2022
Q3 | $6.01M | Sell |
11,859
-103
| -0.9% | -$57.6K | 1.83% | 23 |
|
|
2022
Q2 | $6.5M | Sell |
11,962
-101
| -0.8% | -$55.6K | 1.76% | 26 |
|
|
2022
Q1 | $7.13M | Hold |
12,063
| – | – | 1.61% | 27 |
|
|
2021
Q4 | $8.05M | Sell |
12,063
-22
| -0.2% | -$13.7K | 1.68% | 26 |
|
|
2021
Q3 | $6.91M | Buy |
12,085
+490
| +4% | +$269K | 1.52% | 26 |
|
|
2021
Q2 | $5.85M | Sell |
11,595
-1,002
| -8% | -$473K | 1.34% | 27 |
|
|
2021
Q1 | $5.75M | Buy |
12,597
+50
| +0.4% | +$23.9K | 1.42% | 24 |
|
|
2020
Q4 | $5.84M | Sell |
12,547
-75
| -0.6% | -$35.2K | 1.68% | 23 |
|
|
2020
Q3 | $5.57M | Hold |
12,622
| – | – | 1.87% | 23 |
|
|
2020
Q2 | $4.57M | Sell |
12,622
-160
| -1% | -$53.6K | 1.71% | 23 |
|
|
2020
Q1 | $3.63M | Buy |
12,782
+23
| +0.2% | +$7.25K | 1.77% | 23 |
|
|
2019
Q4 | $4.14M | Sell |
12,759
-200
| -2% | -$60.6K | 1.53% | 26 |
|
|
2019
Q3 | $3.77M | Buy |
12,959
+100
| +0.8% | +$28.6K | 1.47% | 25 |
|
|
2019
Q2 | $3.78M | Buy |
12,859
+100
| +0.8% | +$27.5K | 1.51% | 23 |
|
|
2019
Q1 | $3.49M | Buy |
12,759
+10,125
| +384% | +$2.52M | 1.45% | 23 |
|
|
2018
Q4 | $589K | Hold |
2,634
| – | – | 0.3% | 46 |
|
|
2018
Q3 | $643K | Sell |
2,634
-1,200
| -31% | -$276K | 0.27% | 46 |
|
|
2018
Q2 | $794K | Hold |
3,834
| – | – | 0.33% | 44 |
|
|
2018
Q1 | $792K | Sell |
3,834
-650
| -14% | -$136K | 0.36% | 38 |
|
|
2017
Q4 | $851K | Hold |
4,484
| – | – | 0.36% | 39 |
|
|
2017
Q3 | $848K | Hold |
4,484
| – | – | 0.36% | 39 |
|
|
2017
Q2 | $782K | Hold |
4,484
| – | – | 0.32% | 39 |
|
|
2017
Q1 | $689K | Hold |
4,484
| – | – | 0.28% | 41 |
|
|
2016
Q4 | $633K | Sell |
4,484
-63
| -1% | -$9.29K | 0.28% | 45 |
|
|
2016
Q3 | $723K | Buy |
4,547
+63
| +1% | +$9.71K | 0.33% | 41 |
|
|
2016
Q2 | $663K | Hold |
4,484
| – | – | 0.31% | 40 |
|
|
2016
Q1 | $635K | Hold |
4,484
| – | – | 0.28% | 42 |
|
|
2015
Q4 | $636K | Hold |
4,484
| – | – | 0.31% | 40 |
|
|
2015
Q3 | $548K | Hold |
4,484
| – | – | 0.28% | 40 |
|
|
2015
Q2 | $582K | Hold |
4,484
| – | – | 0.27% | 41 |
|
|
2015
Q1 | $602K | Hold |
4,484
| – | – | 0.28% | 40 |
|
|
2014
Q4 | $562K | Hold |
4,484
| – | – | 0.26% | 42 |
|
|
2014
Q3 | $546K | Hold |
4,484
| – | – | 0.27% | 41 |
|
|
2014
Q2 | $529K | Sell |
4,484
-245
| -5% | -$28.8K | 0.25% | 41 |
|
|
2014
Q1 | $569K | Hold |
4,729
| – | – | 0.29% | 42 |
|
|
2013
Q4 | $527K | Sell |
4,729
-300
| -6% | -$29.8K | 0.27% | 41 |
|
|
2013
Q3 | $463K | Hold |
5,029
| – | – | 0.26% | 40 |
|
|
2013
Q2 | $426K | Buy |
+5,029
| New | +$419K | 0.25% | 43 |
|
Other funds holding TMO
McRae Capital Management's TMO Position: Q2 2026 in Review
McRae Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 1.3% in Q2 2026, selling an estimated $178K and leaving 28,388 shares worth $14.2M. The position accounts for 2.8% of the portfolio, ranked #15.
McRae Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.9M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- McRae Capital Management held 28,388 shares of Thermo Fisher Scientific worth $14.2M as of Q2 2026.
- McRae Capital Management sold 370 Thermo Fisher Scientific shares in Q2 2026, an estimated $178K.
- Thermo Fisher Scientific made up 2.8% of McRae Capital Management's portfolio in Q2 2026, its #15 holding.
- McRae Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- McRae Capital Management's Thermo Fisher Scientific position peaked at $16.9M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.